{"id":"W2025069975","doi":"10.1016/j.parkreldis.2010.04.008","title":"Trials of neuroprotective therapies for Parkinson’s disease: Problems and limitations","year":2010,"lang":"en","type":"review","venue":"Parkinsonism & Related Disorders","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Rasagiline; Neuroprotection; Pramipexole; Levodopa; Medicine; Parkinson's disease; Clinical trial; Dopamine; Ropinirole; Selegiline; Neuroscience; Blinding; Pharmacology; Disease; Psychology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009742157,0.000917176,0.003622665,0.0005505146,0.0002818854,0.00006121967,0.0002162227,0.0007181345,0.00005399356],"category_scores_gemma":[0.001900658,0.0006971825,0.001727407,0.0004503971,0.0003036787,0.0001132441,0.00007136186,0.0007317901,0.0000205447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007827695,"about_ca_system_score_gemma":0.0006088302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002917711,"about_ca_topic_score_gemma":0.00002363301,"domain_scores_codex":[0.9956632,0.0005604366,0.0017083,0.00109269,0.0004245448,0.0005508467],"domain_scores_gemma":[0.9953176,0.001723414,0.001548747,0.0007196487,0.0001756042,0.0005149826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002093117,0.000658098,0.00002103746,0.008249007,0.002103987,0.00001166453,0.0003222803,0.000001554612,0.000006724008,0.0005076888,0.00007966105,0.987829],"study_design_scores_gemma":[0.003271658,0.0005069719,0.0001999409,0.004699462,0.010294,0.00002076227,0.00005371641,0.0000503146,0.000002882589,0.006740687,0.973619,0.0005405549],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002239061,0.9878014,0.0002910562,0.0002783907,0.0004547744,0.009231762,0.0009007971,0.0001521386,0.0006658037],"genre_scores_gemma":[0.002838693,0.9904278,0.00116174,0.00004352091,0.00007765143,0.004094956,0.0007021419,0.0002300552,0.0004234448],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9872884,"threshold_uncertainty_score":0.999548,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0778353403857552,"score_gpt":0.331763888767806,"score_spread":0.2539285483820509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}